No Tax Breaks for Drug Ads Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 9021.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. SLOTKIN, as printed in the Congressional Record (Vol. 170, No. 115, July 11, 2024, Page H4626):
  To make all Laws which shall be necessary and proper for carrying into Execution the foregoing Powers, and all other Powers vested by this Constitution in the Government of the United States, or in any Department or Officer thereof. The single subject of this legislation is: Prohibit the deduction of expenses relating to direct-to- consumer advertising of presciption drugs.
  Source: Congress.gov, Congressional Record July 11, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  376 characters

  Congress.gov bill record

  H.R. 9021, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/9021

  Record last updated by Congress.gov

  November 15, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  91bfe14420d22560bb41701eb1e1f9c4e982ffd1a776b94a2cba79df52669e38

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of November 15, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 9021, last updated November 15, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.